In addition to CREB and NF1, previously established targets of miR-9 in glioma stem cells, such as CAMTA1 [18] and JAK1/2 [35], might contribute to the function of miR-9 in glioma cells, although further investigation will be required. This evidence concerns the gene CREB1 and central nervous system cancer.